Passage Bio Inc (PASG)

Feb 21, 2025

Layoff Tracker: Spotlight Goes Dark After Disappointing Preclinical Data for CRISPR Platform - BioSpace

Feb 21, 2025

Feb 21, 2025

Passage Bio Inc to Host Earnings Call - ACCESS Newswire

Feb 21, 2025

Feb 21, 2025

Passage Bio (NASDAQ:PASG) versus SpringWorks Therapeutics (NASDAQ:SWTX) Head to Head Review - Defense World

Feb 21, 2025

Feb 16, 2025

Passage Bio will again trim workforce in latest cost-cutting move - The Business Journals

Feb 16, 2025

Feb 13, 2025

Passage Bio CFO sells shares worth $1,685 - MSN

Feb 13, 2025

Feb 13, 2025

Fierce Biotech Layoff Tracker 2025: Encoded trims 29% of team; Inventiva halves staff - Fierce Biotech

Feb 13, 2025

Feb 12, 2025

Passage Bio CFO sells shares worth $1,685 By Investing.com - Investing.com UK

Feb 12, 2025

Feb 12, 2025

2024 Q4 Job Market Report: Biopharma Job Postings Slowed as Layoffs Continued - BioSpace

Feb 12, 2025

Feb 03, 2025

Passage Bio shares transition to Nasdaq Capital Market - MSN

Feb 03, 2025

Feb 01, 2025

Passage Bio shares transition to Nasdaq Capital Market By Investing.com - Investing.com South Africa

Feb 01, 2025

Jan 25, 2025

TELA Bio Grants Inducement Stock Units to New Employees - MyChesCo

Jan 25, 2025

Jan 20, 2025

Passage Bio Out-Licenses Rare Disease Programs to GEMMA Biotherapeutics - MSN

Jan 20, 2025

Jan 17, 2025

Annovis Bio Secures U.S. Patent for Neuroprotective Drug Buntanetap - MyChesCo

Jan 17, 2025

Jan 14, 2025

Orbimed Advisors LLC Reduces Stake in Passage Bio Inc - GuruFocus.com

Jan 14, 2025

Jan 14, 2025

Orbimed advisors reduces stake in Passage Bio for $142,223 By Investing.com - Investing.com South Africa

Jan 14, 2025

Jan 14, 2025

Passage Bio Reports Promising Data in Trial for Frontotemporal Dementia Treatment - MSN

Jan 14, 2025

Jan 14, 2025

Orbimed advisors reduces stake in Passage Bio for $142,223 - Investing.com

Jan 14, 2025

Jan 14, 2025

Gryphon Bio, Inc. Pioneers Novel Blood Biomarker Panel to Monitor Treatment Journey for Patients with Traumatic Brain Injury and Alzheimer's - BioSpace

Jan 14, 2025

Jan 13, 2025

Passage Bio Cutting 55% of Staff to Help Extend Cash Runway - BioSpace

Jan 13, 2025

Jan 13, 2025

Geode Capital Management LLC Has $351,000 Position in Nutriband Inc. (NASDAQ:NTRB) - Defense World

Jan 13, 2025

Jan 13, 2025

Passage Bio, Inc. (NASDAQ:PASG) Shares Acquired by Geode Capital Management LLC - Defense World

Jan 13, 2025

Jan 13, 2025

Passage Bio (NASDAQ:PASG) Announces Restructuring Plan and Financial Update - Defense World

Jan 13, 2025

Jan 13, 2025

Head-To-Head Comparison: Passage Bio (NASDAQ:PASG) vs. JATT Acquisition (NYSE:JATT) - Defense World

Jan 13, 2025